About Current Peptide Compliance
Quality · Regulatory · Post-Market Sciences
Our Mission
Current Peptide Compliance (cPC) exists to make regulatory compliance accessible and actionable for peptide developers and distributors. We believe that strong quality systems should accelerate innovation — not slow it down.
The peptide industry sits at a unique regulatory crossroads. Products may fall under pharmaceutical cGMP, compounding pharmacy rules, research-use-only classifications, or dietary supplement frameworks — sometimes simultaneously. This complexity creates real risk for companies that lack specialized compliance guidance.
We founded cPC to fill that gap. Our team brings deep experience in pharmaceutical quality systems, FDA regulatory affairs, and post-market surveillance — all focused exclusively on the peptide sector.
What Sets Us Apart
Peptide-Only Focus
We do not dabble. Every SOP, every regulatory strategy, and every post-market program we build is designed for the specific challenges of peptide products.
Practitioner Experience
Our consultants have operated inside regulated environments — not just advised from the outside. We understand what it takes to pass inspections and maintain compliance day-to-day.
Turnkey Delivery
We deliver ready-to-use systems — not binders of theory. Our SOP packages, QMS frameworks, and monitoring programs are built for implementation on Day 1.
Regulatory Expertise
Our team maintains current expertise across the full spectrum of peptide-applicable regulations, including FDA 21 CFR Parts 210, 211, and 600; USP chapters 797 and 800; FDCA Sections 503A and 503B; ICH guidelines Q7, Q9, and Q10; DSCSA supply chain requirements; and international frameworks from the EMA, MHRA, and Health Canada.
Current Peptide Compliance 